Kombinirano liječenje senilne neovaskularne makularne degeneracije primjenom bevacizumaba i fotodinamske terapije : doktorski rad
Introduction: Age-Related Macular Degeneration is a leading cause of severe visual loss in
population over 50 in Western countries with neovascular subtype accounting for the most of
severe cases. Available treatment modalities including Vascular Endothelial Growth Factor
inhibitors (antiVEGF) and verteporfin photodynamic therapy (PDT) are of limited efficiency
and require prolonged treatment.…
Atbalstītāji
- Gabrić, Nikica
Autors
- Lazić, Ratimir
Izdevējs
- University of Rijeka. Faculty of Medicine.
Temats
- BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.
- Surgery. Orthopaedics. Ophthalmology
- AMD
- bevacizumab
- PDT
- verteporfin
- antiVEGF
Digitālais objekts veids
- info:eu-repo/semantics/doctoralThesis
- text
Datums
- 2010-12-23
- 2010-12-23
Atbalstītāji
- Gabrić, Nikica
Autors
- Lazić, Ratimir
Izdevējs
- University of Rijeka. Faculty of Medicine.
Temats
- BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.
- Surgery. Orthopaedics. Ophthalmology
- AMD
- bevacizumab
- PDT
- verteporfin
- antiVEGF
Digitālais objekts veids
- info:eu-repo/semantics/doctoralThesis
- text
Datums
- 2010-12-23
- 2010-12-23
Piegādājošā iestāde
Agregators
Tiesību statuss šim digitālajam objektam (ja nav norādīts citādi)?
- http://rightsstatements.org/vocab/InC/1.0/
Identifikators
- https://dr.nsk.hr/islandora/object/svkri:3122
- https://urn.nsk.hr/urn:nbn:hr:188:892351
- https://www.unirepository.svkri.uniri.hr/islandora/object/svkri:3122
- https://dr.nsk.hr/islandora/object/svkri%3A3122/datastream/TN/view/
Formāts
- application/pdf
Valoda
- hrv
Nodrošinošā valsts
- Croatia
Kolekcijas nosaukums
Pirmo reizi publicēts Europeana
- 2019-04-05T13:44:36.130Z
Pēdējoreiz atjaunināts no piegādājošās iestādes
- 2019-04-05T13:44:36.130Z